Ryan Savitz serves as the Chief Financial Officer, Chief Business Officer, and Treasurer at Dianthus Therapeutics Inc., a biopharmaceutical company focused on developing innovative therapies for patients with severe autoimmune and inflammatory diseases. In his multifaceted role, Savitz is responsible for overseeing the company's financial operations, strategic planning, and business development initiatives. His leadership is crucial in driving Dianthus' growth and ensuring the company's financial health as it advances its pipeline of novel treatments. Prior to joining Dianthus Therapeutics, Savitz held several senior leadership positions in the life sciences industry. He has a proven track record of successfully managing complex financial strategies and transactions, including mergers and acquisitions, financings, and partnerships. Savitz's career highlights include his tenure at Abeona Therapeutics, where he served as CFO and played a pivotal role in securing significant funding and advancing the company's gene therapy programs. His expertise in financial management and business development has been instrumental in helping biopharmaceutical companies navigate the challenges of drug development and commercialization. Savitz's contributions to Dianthus extend beyond his financial acumen. He is deeply involved in shaping the company's strategic direction, collaborating with the executive team to identify and pursue opportunities that align with Dianthus' mission to bring transformative therapies to patients. His strategic vision and dedication to the company's goals have made him an invaluable asset to Dianthus as it works to revolutionize the treatment landscape for autoimmune and inflammatory diseases.